Clinical Trial: S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: Evaluation of Suramin in Advanced Adrenal Cortical Carcinoma, Phase II

Brief Summary:

RATIONALE: Some tumors need growth factors produced by the body to keep growing. Suramin may interfere with the growth factor and stop the tumor from growing.

PURPOSE: Phase II trial to study the effectiveness of suramin in treating patients with stage III or stage IV adrenocortical cancer.